| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJPATH.2017.12.014 |
| P698 | PubMed publication ID | 29366678 |
| P50 | author | Sheng-Fan Wang | Q80290927 |
| P2093 | author name string | Fu-Tong Liu | |
| Li-Chung Hsu | |||
| Huan-Yuan Chen | |||
| Yu-Jung Chen | |||
| Jia-Tsrong Jan | |||
| I-Chun Weng | |||
| Ming-Hsiang Hong | |||
| Tzu-Han Lo | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammasome complex | Q412405 |
| P304 | page(s) | 1031-1042 | |
| P577 | publication date | 2018-01-31 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation | |
| P478 | volume | 188 |
| Q49895966 | Distinct CD40L receptors mediate inflammasome activation and secretion of IL-1β and MCP-1 in cultured human retinal pigment epithelial cells. |
| Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
| Q92377188 | Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease |
| Q99711569 | Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider |
| Q60915189 | Influenza virus N-linked glycosylation and innate immunity |
| Q92446931 | MGL1 Receptor Plays a Key Role in the Control of T. cruzi Infection by Increasing Macrophage Activation through Modulation of ERK1/2, c-Jun, NF-κB and NLRP3 Pathways |
| Q95293148 | Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy |
| Q89665967 | Rhein Suppresses Lung Inflammatory Injury Induced by Human Respiratory Syncytial Virus Through Inhibiting NLRP3 Inflammasome Activation via NF-κB Pathway in Mice |
| Q94545514 | The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis |
Search more.